Cargando…
Pharmacological Targeting of GLUT1 to Control Autoreactive T Cell Responses
An increasing body of evidence indicates that bio-energetic metabolism of T cells can be manipulated to control T cell responses. This potentially finds a field of application in the control of the T cell responses in autoimmune diseases, including in type 1 diabetes (T1D). Of the possible metabolic...
Autores principales: | Di Dedda, Carla, Vignali, Debora, Piemonti, Lorenzo, Monti, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801424/ https://www.ncbi.nlm.nih.gov/pubmed/31597342 http://dx.doi.org/10.3390/ijms20194962 |
Ejemplares similares
-
Monitoring Inflammation, Humoral and Cell-mediated Immunity in
Pancreas and Islet Transplants
por: Monti, Paolo, et al.
Publicado: (2015) -
T-cell Metabolism as a Target to Control Autoreactive T Cells in β-Cell Autoimmunity
por: Bordignon, Carlotta, et al.
Publicado: (2017) -
Targeting Homeostatic T Cell Proliferation to Control Beta-Cell Autoimmunity
por: Vignali, Debora, et al.
Publicado: (2016) -
Homeostatic T Cell Proliferation after Islet Transplantation
por: Monti, Paolo, et al.
Publicado: (2013) -
Induction of autoreactive B cells allows priming of autoreactive T cells
Publicado: (1991)